Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Linda Callaghan

Psychiatry Washington, IN Medical Doctor

NPI 1477768786 CMS profile 338972

1402 Grand Ave, Washington, IN 47501

Open in the dashboard

General payments

$3,223

215 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Linda Callaghan of Washington, IN is reported in the CMS Open Payments database as having received $3,223 across 215 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $365 18
2024 General $885 54
2023 General $780 58
2022 General $397 30
2021 General $455 30
2020 General $165 13
2019 General $176 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Linda Callaghan
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Linda Callaghan were reported at $365. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Linda Callaghan Psychiatry median Middle half National median
2019 $176 $184 $59–$605 $163
2020 $165 $119 $36–$372 $114
2021 $455 $143 $43–$576 $132
2022 $397 $153 $50–$590 $149
2023 $780 $170 $56–$651 $160
2024 $885 $179 $57–$673 $164
2025 $365 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $539 53 payments
  2. Vanda Pharmaceuticals Inc. $357 16 payments
  3. Alkermes, Inc. $311 22 payments
  4. ITI, Inc. $280 15 payments
  5. Otsuka America Pharmaceutical, Inc. $279 17 payments
  6. Teva Pharmaceuticals USA, Inc. $264 15 payments
  7. Supernus Pharmaceuticals, Inc. $162 8 payments
  8. Sunovion Pharmaceuticals Inc. $154 12 payments
  9. Indivior Inc. $138 9 payments
  10. Lundbeck LLC $121 7 payments
  11. Other $620 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,168 212 payments
  2. Education $55 3 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR $525 52 payments
  2. FANAPT $357 16 payments
  3. ARISTADA Cns $294 21 payments
  4. ARISTADA Cns $294 21 payments
  5. CAPLYTA $260 14 payments
  6. LYBALVI $255 19 payments
  7. ARISTADA Cns $255 19 payments
  8. ARISTADA Cns $255 19 payments
  9. REXULTI $236 14 payments
  10. LATUDA $154 12 payments
  11. Other $1,635 98 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 72 drugs

Part D claims

3,386

Median for Psychiatry: 574

Drug cost

$490,714

Median for Psychiatry: $27,624

Branded share of claims

23.7%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Caplyta Lumateperone Tosylate Brand 72 $131,390
Vraylar Cariprazine Hcl Brand 60 $97,026
Trintellix Vortioxetine Hydrobromide Brand 77 $55,336
Rexulti Brexpiprazole Brand 25 $37,774
Auvelity Dextromethorphan Hbr/Bupropion Brand 24 $27,347
Fetzima Levomilnacipran Hcl Brand 40 $20,183
Belsomra Suvorexant Brand 37 $16,708
Azstarys Serdexmethylphen/Dexmethylphen Brand 21 $9,048
Quviviq Daridorexant Hcl Brand 16 $7,520
Divalproex Sodium Generic 56 $7,222

The 10 drugs with the highest cost, of 72 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$37,608

Medicare's payments for the services billed

Medicare patients

98

Average age 69

Services billed

502

63 women, 35 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 71%
Arthritis 52%
Alzheimer's or dementia 40%
Diabetes 36%
COPD 29%
Chronic kidney disease 28%
Ischemic heart disease 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 14 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
FANAPT
  • Vanda Pharmaceuticals Inc. $169
$169 — —
REXULTI
  • Otsuka America Pharmaceutical, Inc. $85
  • Lundbeck LLC $19
$104 25 —
ARISTADA
  • Alkermes, Inc. $99
$99 — —
Qelbree
  • Supernus Pharmaceuticals, Inc. $85
$85 — —
JORNAY PM
  • Ironshore Pharmaceuticals Inc. $73
$73 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 14 in the dashboard with a free account

Records

215 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record